Sweetwater Farms

In June 2026, Sweetwater Farms concentrated 77.94% of sales in Flower, where year-over-year sales rose 67.89% even as month-over-month slipped 4.99%, while Pre-Roll held 17.26% share with a 91.23% year-over-year gain but a 21.45% month-over-month decline. Vapor Pens contracted to 3.38% share with a 29.50% year-over-year drop and a 38.85% month-over-month decline, contrasted by Concentrates at 1.42% share that expanded 321.85% year-over-year and inched up 1.17% month-over-month. Average price across the brand eased 1.15% year-over-year to $16.91, while Flower’s average price sat at $24.30, implying the mix is tilting toward lower-priced units despite Flower dominance. The pattern implies a consolidation around Flower for scale and margin protection, while Pre-Roll volatility and Vapor Pens contraction indicate de-prioritization of inhalable variety in favor of core SKU velocity.

Given a Flower rank of 5 in Washington and Flower’s 77.94% mix, Sweetwater Farms is positioned as a category specialist rather than a broad portfolio player, using Flower gains (+67.89% year-over-year) to offset softness in Vapor Pens (−29.50% year-over-year) and the sharp month-over-month pullback in Pre-Roll (−21.45%). The 321.85% year-over-year surge in Concentrates alongside only 1.42% share and a 1.17% month-over-month lift suggests a test-and-scale posture that adds headroom without diluting focus, while the 4.99% month-over-month dip in Flower signals capacity or shelf-cycle timing more than demand erosion. The implication is that maintaining a top-five Flower position while gradually scaling Concentrates can stabilize mix risk and price architecture as average price drifts down 1.15% year-over-year, anchoring growth in core while selectively rebuilding breadth.